Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.

MLA

Lin, Chih-Lang, et al. “Significant Renoprotective Effect of Telbivudine during Preemptive Antiviral Therapy in Advanced Liver Cancer Patients Receiving Cisplatin-Based Chemotherapy: A Case-Control Study.” Scandinavian Journal of Gastroenterology, vol. 49, no. 12, Dec. 2014, pp. 1456–64. EBSCOhost, https://doi.org/10.3109/00365521.2014.962604.

APA

Lin, C.-L., Chien, R.-N., Yeh, C., Hsu, C.-W., Chang, M.-L., Chen, Y.-C., & Yeh, C.-T. (2014). Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study. Scandinavian Journal of Gastroenterology, 49(12), 1456–1464. https://doi.org/10.3109/00365521.2014.962604

Chicago

Lin, Chih-Lang, Rong-Nan Chien, Charisse Yeh, Chao-Wei Hsu, Ming-Ling Chang, Yi-Cheng Chen, and Chau-Ting Yeh. 2014. “Significant Renoprotective Effect of Telbivudine during Preemptive Antiviral Therapy in Advanced Liver Cancer Patients Receiving Cisplatin-Based Chemotherapy: A Case-Control Study.” Scandinavian Journal of Gastroenterology 49 (12): 1456–64. doi:10.3109/00365521.2014.962604.